File size: 3,433 Bytes
44f2895 9dcaf58 44f2895 aff5251 fe05a47 314af26 fe05a47 314af26 fe05a47 9dcaf58 fe05a47 314af26 fe05a47 44f2895 |
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 |
---
license: mit
---
# HIV_PR_resist model
## Table of Contents
- [Summary](#model-summary)
- [Model Description](#model-description)
- [Intended Uses & Limitations](#intended-uses-&-limitations)
- [How to Use](#how-to-use)
- [Training Data](#training-data)
- [Training Procedure](#training-procedure)
- [Preprocessing](#preprocessing)
- [Training](#training)
- [Evaluation Results](#evaluation-results)
- [BibTeX Entry and Citation Info](#bibtex-entry-and-citation-info)
## Summary
The HIV-BERT-Protease-Resistance model was trained as a refinement of the HIV-BERT model (insert link) and serves to better predict whether an HIV protease sequence will be resistant to certain protease inhibitors. HIV-BERT is a model refined from the [ProtBert-BFD model](https://huggingface.co/Rostlab/prot_bert_bfd) to better fulfill HIV-centric tasks. This model was then trained using HIV protease sequences from the [Stanford HIV Genotype-Phenotype Database](https://hivdb.stanford.edu/pages/genotype-phenotype.html), allowing even more precise prediction protease inhibitor resistance than the HIV-BERT model can provide.
## Model Description
The HIV-BERT-Protease-Resistance model is intended to predict the likelihood that an HIV protease sequence will be resistant to protease inhibitors. The protease gene is responsible for cleaving viral proteins into their active states, and as such is an ideal target for antiretroviral therapy. Annotation programs designed to predict and identify protease resistance using known mutations already exist, however with varied results. The HIV-BERT-Protease-Resistance model is designed to provide an alternative, NLP-based mechanism for predicting resistance mutations when provided with an HIV protease sequence.
## Intended Uses & Limitations
This tool can be used as a predictor of protease resistance mutations within an HIV genomic sequence. It should not be considered a clinical diagnostic tool.
## How to use
*Prediction example of protease sequences*
## Training Data
This model was trained using the [damlab/HIV-PI dataset](https://huggingface.co/datasets/damlab/HIV_PI) using the 0th fold. The dataset consists of 1959 sequences (approximately 99 tokens each) extracted from the Stanford HIV Genotype-Phenotype Database.
## Training Procedure
### Preprocessing
As with the [rostlab/Prot-bert-bfd model](https://huggingface.co/Rostlab/prot_bert_bfd), the rare amino acids U, Z, O, and B were converted to X and spaces were added between each amino acid. All strings were concatenated and chunked into 256 token chunks for training. A random 20% of chunks were held for validation.
### Training
The [damlab/HIV-BERT model](https://huggingface.co/damlab/HIV_BERT) was used as the initial weights for an AutoModelforClassificiation. The model was trained with a learning rate of 1E-5, 50K warm-up steps, and a cosine_with_restarts learning rate schedule and continued until 3 consecutive epochs did not improve the loss on the held-out dataset. As this is a multiple classification task (a protein can be resistant to multiple drugs) the loss was calculated as the Binary Cross Entropy for each category. The BCE was weighted by the inverse of the class ratio to balance the weight across the class imbalance.
## Evaluation Results
*Need to add*
## BibTeX Entry and Citation Info
[More Information Needed] |